Home > Chemicals & Materials > Specialty Chemicals > Custom Synthesis > Choline Bitartrate Market

Choline Bitartrate Market Size

Report ID: GMI5241
Published Date: Mar 2022
Report Format: PDF

Download Free Sample

Choline Bitartrate Market Size

Choline Bitartrate Market size exceeded USD 410 million in 2021 and is estimated to grow at over 6% CAGR between 2022 and 2028. Choline bitartrate is an active pharmaceutical ingredient formed by the mixture of choline and tartaric acid. Choline is an essential nutrient precursor to acetylcholine. It helps in synthesis of sphingomyelin and phosphatidylcholine which major constitutes of cell membrane. Choline bitartrate plays an important role in lipid transportation, supports cell membrane, healthy metabolism, DNA synthesis and early brain development.

To get key market trends

Download Free Sample

Choline bitartrate is used in place of natural choline as it is easily digestible and has better immersion rate. There are three types of choline bitartrate namely choline d-bitartrate, choline l-bitartrate and choline dl-bitartrate. Increasing acceptance of it in infant formula, dietary supplements, fortified food & beverage industry is expected to drive choline bitartrate market demand. Rising awareness regarding essential nutrition and growing emphasis on preventive health care will propel the demand for choline bitartrate in upcoming years.

Choline Bitartrate Market Report Attributes
Report Attribute	Details
Base Year:	2021
Choline Bitartrate Market Size in 2021:	410.2 Million (USD)
Forecast Period:	2022 to 2028
Forecast Period 2022 to 2028 CAGR:	6%
2028 Value Projection:	620 Million (USD)
Historical Data for:	2017 to 2028
No. of Pages:	200
Tables, Charts & Figures:	175
Segments covered:	Type, Application
Growth Drivers:	North America: Growing pharmaceutical sector along with presence of large manufacturing base Asia Pacific: Increasing demand for infant formula Europe: High demand for fortified food & beverages
Pitfalls & Challenges:	Increasing consumer inclination towards natural ingredients

Learn more about the key segments shaping this market

Download Free Sample

Covid-19 pandemic enforced manufacturing units and factories to shut down temporarily this factor significantly hampered manufacturing operations of the choline bitartrate market. However, as food & beverages, pharmaceuticals, and nutritional supplements were considered as an essential commodity, their production continued during pandemic by taking precautionary measures. This factor caused a demand and supply gap between manufacturers and raw material suppliers which affected the overall market growth.

Various regulations and standard specifications for the quality, labelling, advertisement, and formulation, of choline bitartrate for the usage in food products is anticipated to hinder the market growth at some extend. For instance, EU (EU) No 609/2013 prohibits the use of infant’s pictures for presentations, packaging and advertising of infant formula. It also states that any text or picture should not idealize use of such formula. Advertising and labeling for infant formula should be designed in such a way that it does not discourage breast-feeding.

Authors: Kunal Ahuja, Sarita Bayas

Frequently Asked Questions (FAQ) :

The global choline bitartrate industry size had crossed USD 410 million in 2021 and is poised to record a 6% CAGR between 2022 and 2028 owing to growing adoption in the synthesis of sphingomyelin and phosphatidylcholine.

Choline bitartrate plays an essential role in lipid transportation, supporting cell membrane, healthy metabolism, DNA synthesis as well as early brain development.

The baby food application segment in the choline bitartrate market is pegged to register over USD 185 million by 2028 on account of the thriving need for brain development.

The choline bitartrate market in North America is expected to generate USD 215 million in annual revenue by 2028 due to the robust presence of a large number of pharmaceutical as well as nutraceutical companies.